Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Pharmaceuticals (Basel, Switzerland)|October 28, 2023
Drugs for Diabetes: From Pharmacology to Clinical ApplicationSwayam Prakash Srivastava
American Journal of Physiology. Renal Physiology|August 17, 2023
Loss of endothelial glucocorticoid receptor accelerates organ fibrosis in <i>db/db</i> miceSwayam Prakash Srivastava, Julie E Goodwin
Cells|June 6, 2020
Cancer Biology and Prevention in DiabetesSwayam Prakash Srivastava, Julie E Goodwin
Biorxiv : the Preprint Server for Biology|March 30, 2023
Loss of endothelial glucocorticoid receptor accelerates organ fibrosis in <i>db/db</i> miceSwayam Prakash Srivastava, Julie E Goodwin
Biomed Research International|October 4, 2013
MicroRNAs in kidney fibrosis and diabetic nephropathy: roles on EMT and EndMTSwayam Prakash Srivastava, Daisuke Koya, Keizo Kanasaki
Frontiers in Pharmacology|December 28, 2020
Loss of Mitochondrial Control Impacts Renal HealthSwayam Prakash Srivastava, Keizo Kanasaki, Julie E Goodwin
Fibrogenesis & Tissue Repair|September 11, 2014
Lipid mediators in diabetic nephropathySwayam Prakash Srivastava, Sen Shi, Daisuke Koya, et al.
British Journal of Pharmacology|May 1, 2020
Metabolic reprogramming by N-acetyl-seryl-aspartyl-lysyl-proline protects against diabetic kidney diseaseSwayam Prakash Srivastava, Julie E Goodwin, Keizo Kanasaki, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2021
Coronavirus Disease (COVID)-19 and Diabetic Kidney DiseaseSwayam Prakash Srivastava, Rohit Srivastava, Subhash Chand, et al.
Genes|February 23, 2020
Inhibition of Angiotensin-Converting Enzyme Ameliorates Renal Fibrosis by Mitigating DPP-4 Level and Restoring Antifibrotic MicroRNAsSwayam Prakash Srivastava, Julie E Goodwin, Keizo Kanasaki, et al.
Pageof 5